Is MiniMed Group, Inc. (MMED) Overvalued?
We dive into why MiniMed Group, Inc. (MMED) could be considered overvalued on 2026-07-29, based on AAII’s Value Score and Grade.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company’s platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. MiniMed Group, Inc. operates as a subsidiary of Medtronic plc.
Commentary & Analysis
Why MiniMed Group, Inc.’s (MMED) Stock Is Up 5.04%
As of Friday, July 17, MiniMed Group, Inc.’s MMED share price has surged by 5.04%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why MiniMed Group, Inc.’s (MMED) Stock Is Up 6.16%
As of Thursday, July 16, MiniMed Group, Inc.’s MMED share price has surged by 6.16%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why MiniMed Group, Inc.’s (MMED) Stock Is Down 5.53%
As of Tuesday, July 14, MiniMed Group, Inc.’s MMED share price has dipped by 5.53%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why MiniMed Group, Inc.’s (MMED) Stock Is Up 7.24%
As of Wednesday, June 24, MiniMed Group, Inc.’s MMED share price has surged by 7.24%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | MMED | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $5,091.7 | $334.8 | 67% |
|
| Shares Out (Mil) | 268.1 | 41.7 | 81% |
|
| Institutional Ownership | 100.0% | 77.3% | 99% |
|
| Float (Mil) | 27.5 | 34.7 | 35% |
|
| Beta | na | 0.86 | na |
|
| Avg Daily Volume (000s) | 1,364 | 266 | 76% |
|
| Price Change (52-week) |
na | 60.7% | na |
|
| Growth | MMED | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (5.8%) | na |
|
| EPS (5yr) | na | 10.7% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (16.1%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 5 | 7 | 7 | |
| Current EPS | $0.090 | $0.629 | $0.661 | |
| Month Ago EPS | $0.115 | $0.659 | $0.681 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | $0.133 | $0.671 | $0.828 | |
| Year/Year Chg | (113.0%) | (148.4%) | (236.2%) | |
| Financials | MMED | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,102 | $152 | 67% |
|
| Net Income (TTM) (Mil) | ($333) | ($11) | 4% |
|
| EPS (TTM) | ($1.298) | ($0.500) | 19% |
|
| Operating Cash Flow (TTM) (Mil) | ($197) | ($2) | 3% |
|
| Net Cash Flow (TTM) (Mil) | $287 | $1 | 87% |
|
| Long-Term Debt (Q1) (Mil) | $45 | $22 | 38% |
|
| Enterprise Value (Q1) (Mil) | $3,954 | $304 | 59% |
|
| Valuation | MMED | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.41 | 2.88 | 37% |
|
| P/E | na | 30.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.9 | na |
|
| Ratios | MMED | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 57.1% | 59.1% | 70% |
|
| Net Margin | (10.7%) | (7.7%) | 21% |
|
| ROA | (7.5%) | (13.7%) | 27% |
|
| ROE | (9.6%) | (15.9%) | 28% |
|
| Liabilities to Assets | 22.0% | 44.9% | 14% |
|
| F-Score | 3 | 4 | na |
|
MiniMed Group, Inc. did not pass any screens on 7/30/2026.
